心脏外科
医学
体外循环
变向性
心脏病学
生物标志物
内科学
生物
生物化学
作者
Uri Pollak,Hai Zemmour,Elior Shaked,Judith Magenheim,Ori Fridlich,Amit Korach,Alain Sérraf,David Mishaly,Benjamin Gläser,Ruth Shemer,Yuval Dor
标识
DOI:10.1007/s12265-022-10295-0
摘要
The use of cardiopulmonary bypass (CPB) is thought to cause delayed cardiac damage. DNA methylation-based liquid biopsies are novel biomarkers for monitoring acute cardiac cell death. We assessed cell-free DNA molecules as markers for cardiac damage after open-heart surgery. Novel cardiomyocyte-specific DNA methylation markers were applied to measure cardiac cfDNA in the plasma of 42 infants who underwent open-heart surgery. Cardiac cfDNA was elevated following surgery, reflecting direct surgery-related tissue damage, and declined thereafter in most patients. The concentration of cardiac cfDNA post-surgery correlated with the duration of CPB and aortic cross clamping. Strikingly, cardiac cfDNA at 6 h predicted duration of mechanical ventilation and maximal vasoactive-inotropic score better than did maximal troponin levels. Cardiac cfDNA reveals heart damage associated with CPB, and can be used to monitor cardiac cell death, to predict clinical outcome of surgery and to assess performance of cardioprotective interventions.Graphical abstract
科研通智能强力驱动
Strongly Powered by AbleSci AI